Authors
Latest:
Gene Therapy: Managing the Clinical Trial MinefieldsAdvice for developers in steering gene therapies from concept to trials to hopeful approval in what is an uniquely complex path.
Latest:
Operations: Gateway to Success in Cell and Gene TherapiesLife sciences therapies are moving away from a one-size-fits-all approach to a targeted approach using a patient's own genetic information and immune system to treat previously incurable diseases.
Latest:
Operations: Gateway to Success in Cell and Gene TherapiesLife sciences therapies are moving away from a one-size-fits-all approach to a targeted approach using a patient's own genetic information and immune system to treat previously incurable diseases.
Latest:
Operations: Gateway to Success in Cell and Gene TherapiesLife sciences therapies are moving away from a one-size-fits-all approach to a targeted approach using a patient's own genetic information and immune system to treat previously incurable diseases.
Latest:
Operations: Gateway to Success in Cell and Gene TherapiesLife sciences therapies are moving away from a one-size-fits-all approach to a targeted approach using a patient's own genetic information and immune system to treat previously incurable diseases.
Latest:
Chemotherapy vs Immunotherapy: China's Liver Cancer Market OutlookJianan Huang outlines the market prospects for first-line treatments for liver cancer treatment in China.
Latest:
Reinventing Pharma’s Talent SearchThinning talent pools, combined with evolving industry trends and job-seeker motivations, are testing traditional pharma hiring methods, where targeting new skills and capabilities must become the new norm.
Latest:
Reinventing Pharma’s Talent SearchThinning talent pools, combined with evolving industry trends and job-seeker motivations, are testing traditional pharma hiring methods, where targeting new skills and capabilities must become the new norm.
Latest:
Hiring a Chief Diversity OfficerNine ways pharma companies can maximize a CDO’s potential value and impact on driving innovation as a business mandate.
Latest:
Hiring a Chief Diversity OfficerNine ways pharma companies can maximize a CDO’s potential value and impact on driving innovation as a business mandate.
Latest:
Mapping Out the Future of Cell and Gene TherapyThe cell and gene therapy space remains fertile territory for growth, exploration, and discovery. How applying a data-driven model may be the best way to approach this complex ecosystem and assess the innovations of tomorrow.
Latest:
Succession Planning: It's Not Just for Human ResourcesTeams and organizations that rely solely on the HR function for succession planning are doing themselves a disservice, write Joy Taylor and Kim Lehman.
Latest:
Empowering Women Entrepreneurs in HealthcareThe significant scale that is necessary to break into the healthcare marketplace poses the greatest barrier to entry for women entrepreneurs. Shaleta Dunn outlines strategies that aspiring businesswomen can adopt to foster their success.
Latest:
Life Sciences Organizations Overcome Today’s Biggest Content Management ChallengesOutdated processes and technologies make it difficult for organizations to customize materials without going through repetitive review cycles. Jason Sundberg outlines how two companies addressed these challenges with a combination of modern cloud technology, disciplined process design, and careful change management.
Latest:
STP: Powering Marketing SuccessGary Lyon explores the role and impact of three elements of marketing planning that drive business success: Segmentation, Targeting, and Positioning.
Latest:
Reducing Barriers to Great Patient Care and Supporting Product SuccessAs manufacturers look to commercialize new medicines, it is important to evaluate partners that can provide a fully integrated offering aligned to product performance goals and offer a seamless customer experience.
Latest:
Skills Shortage: An Imminent Threat to Life Sciences InnovationIndustry needs to realize the potential that new treatments and technologies hold and put skills at the top of its collective agenda, write Ian Marison and Peter Levison.
Latest:
Specialized Metrics to Properly Assess AI-Pharma StartupsAI-Pharma companies are 100 times as complex as FinTech companies. Methodologies used to assess them should be 100 times as rigorous, writes Margaretta Colangelo.
Latest:
Specialized Metrics to Properly Assess AI-Pharma StartupsAI-Pharma companies are 100 times as complex as FinTech companies. Methodologies used to assess them should be 100 times as rigorous, writes Margaretta Colangelo.
Latest:
A Strategic Approach to Pharma R&D Portfolio PlanningWeighing the benefits of a deeper quantitative review for pharma.
Latest:
A Strategic Approach to Pharma R&D Portfolio PlanningWeighing the benefits of a deeper quantitative review for pharma.
Latest:
Pharma Social Media Profiles: An AnalysisShrujitha Ramanujam outlines Unmetric's analysis of pharma's social media activity on LinkedIn and Facebook.
Latest:
The AI Patient Arc: Past, Present, FutureThe story of how AI is improving all aspects of life science is still being written. But AI’s future impact on patients’ daily health will be informed and influenced by the work being realized today, writes Opinder Bawa.
Latest:
Survey Spotlights the CFO’s Strategic RiseFindings support the belief that today’s pharma finance teams should be engaged across all functional areas, including regulatory, supply chain, manufacturing, and commercial. What does that mean for current and future CFOs in the industry?
Latest:
Planning Ahead with AstraZeneca's Pam ChengA discussion with Pam Cheng, executive vice president of Operations, Technology at AstraZeneca about making the transition into a Fortune 500 C-Suite role and leadership advice for success.
Latest:
Site Payments: Drilling in on Forecast, Budget IssuesRepurposing existing technology to alleviate traditional ‘pain points’ in ensuring clinical investigator payments transparency
Latest:
Bridging the Generational Chasm in OncologyHow engaging with digital influencers holds the key for medical affairs.
